S.Africa's Eskom: 36% tariff hike needed because of earlier regulatory decisions
There is no requirement for Corbevax to be stored at extremely low temperatures
Botswana is the latest country to approve the use of the Corbevax coronavirus vaccine – and also plans to produce it locally by 2026.
This is according to South African-born biotech billionaire Patrick Soon-Shiong, who made the announcement on a visit to Botswana on Monday.
His NantWorks company has partnered with the Botswana government to set up a vaccine-manufacturing plant – and he was in the southern African country to mark the start of the project.
During his trip, Dr Soon-Shiong said he had organised for Botswana to immediately get access to 100 million doses of the Corbevax vaccine currently in production elsewhere.
He said the protein-based vaccine had been declared safe, worked against every variant and 10 million doses had already been administered, mainly in India and Bangladesh.
The patent-free vaccine, developed by US researchers, is currently being produced in India and there is no requirement for Corbevax to be stored at very low temperatures.
Currently, only 1% of the vaccines used in Africa are produced on the continent – and the latest figures show that only 15% of Africans are fully vaccinated against Covid-19.
Leave a Reply
Be the First to Comment!
You must be logged in to post a comment.
You must be logged in to post a comment.